Guest Contributors
 Olivier Lesueur, Partner at Bionest |
 Tony Letai, Associate Professor, Harvard Medical School and Dana-Farber Cancer Institute |
 Managing Director, Burrill & Company |
 Founder, Rare Genomics Institute |
 Director of the Bioinformatics Core at UC Davis Genome Center |
 Professor, University of Illinois |
 CEO, Assay Depot |
 President, AMP; Director of Genetics Division, ARUP |
 @GholsonLyon |
 Sandy Macrae, CEO of Sangamo |
 President and CEO, BayBio |
 Science Comedian |
 Deputy Office Director of Personalized Medicine, OIR, FDA |
 Professor and Head, Department of Medical Genetics, University of British Columbia |
 Annie Martin, SVP, Global Head of Precision Medicine, Novartis |
 Chief Operating Officer, IDT |
 former CEO, Pacific Biosciences |
 Program Chair, PMWC |
 Assistant Professor, Weill Cornell Medical College |
 Founder, Science Futures |
 President and CEO, My Gene Counsel |
 VP, Boston Healthcare |
 Associate Professor, Leader of the Precision Cancer Medicine Initiative at the Biorepository and Precision Pathology Center at Duke University |
 Dir of Scientific Research, Illumina |
 Director, PGI |
